Dasapan Dasatinib 50mg

dasapan 50mg tablet is indicated as a treatment for individuals over one year old, both adults and children, with chronic myeloid leukemia. the medication is used to treat recent diagnoses of philadelphia chromosome-positive (ph+) in its chronic stage and chronic myeloid leukemia (cml). patients with ph+ acute lymphoblastic leukemia who failed to respond to alternative treatments in the past are also prescribed dasapan 50mg. chronic myeloid leukemia is a type of blood cancer that causes excessive production of white blood cells resulting from mutations in the philadelphia chromosome. this chromosomal abnormality leads to the fusion of the bcr and abl genes, which code for proteins with tyrosine kinase activity. the process affects cell growth, division, and survival. acute lymphoblastic leukemia, the most prevalent type of blood cancer, mainly affects children. this condition is characterized by an uncontrolled proliferation of white blood cells called lymphocytes, which also have an extended lifespan.